Shanghai Fudan Zhangjiang Bio Pharmaceutical Co (DE:FDY) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. has allocated RMB200 million from its idle operational funds to subscribe to a low-risk, principal-guaranteed structured deposit product with SPD Bank, set to start on July 1, 2024. The 30-day investment offers an expected annualized return rate between 1.20% and 2.75%, linked to the EUR/USD exchange rate, without the requirement for shareholder approval.
For further insights into DE:FDY stock, check out TipRanks’ Stock Analysis page.
